Lonza Forms Commercial Partnership with Israeli Firm

Lonza says it has formed a global commercial partnership with phosphatidyl serine manufacturer Lipogen (Haifa, Israel) for the exclusive rights to sell phosphatidyl serine and phosphatidyl serine-based formulations in dietary supplements, medical foods, and food and beverages. The products will be branded and sold under the Lonza name. Lonza intends to roll out launch activities in the U.S. in this quarter, and expand to other regions thereafter. Phosphatidyl serine, which may reduce the risk of dementia and cognitive dysfunction in the elderly as well as reduce...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers